Aims Marketing that promotes mixing caffeinated 'energy' drinks with alcoholic beverages (e.g. Red Bull with vodka) targets young drinkers and conveys the expectation that caffeine will offset the sedating effects of alcohol and enhance alertness. Such beliefs could result in unwarranted risk taking (e.g. driving while intoxicated). The aim of this study was to assess the acute effects of caffeinated versus non-caffeinated alcoholic beverages on a simulated driving task and attention/reaction time. Design We conducted a 2 ¥ 2 between-groups randomized trial in which participants were randomized to one of four conditions: beer and non-alcoholic beer, with and without caffeine added. Caffeine was added in the same proportion as found in a commercially available caffeinated beer (69 mg/12 oz of beer at 4.8% alc. by vol). Participants Participants were 127 non-dependent, heavy episodic, young adult drinkers (age 21-30) who were college students or recent graduates. The target breath alcohol level was 0.12 g%. Measures Driving performance was assessed with a driving simulator; sustained attention/reaction with the Psychomotor Vigilance Task (PVT). Findings Across the driving and attention/reaction time we found main effects for alcohol, with alcohol significantly impairing driving and sustained attention/reaction time, with mainly large statistical effects; however, the addition of caffeine had no main or interaction effects on performance. Conclusion The addition of caffeine to alcohol does not appear to enhance driving or sustained attention/reaction time performance relative to alcohol alone.
INTRODUCTION
'Energy drinks' refer to beverages containing caffeine and sometimes other stimulating herbal products. One hundred and thirty of these products contain more than the 0.02% caffeine limit the US Federal Drug Administration (FDA) requires for soft drinks, typically 80-141 mg caffeine per 8 oz (equivalent to a 5-oz cup of coffee) [1] . As a result of non-traditional youth-oriented marketing strategies (e.g. sponsors of extreme sports, providing free drinks, internet, text-messaging, Facebook, etc.) [2] , 31% of minor teens and 34-51% of 18-24-year-olds report regular consumption of energy drinks [2] . Marketing includes unsubstantiated claims that these drinks will enhance attention, endurance, performance, weight loss and fun, while reducing performance decrements from fatigue or alcohol [3] .
Consumption of energy drinks with alcohol has grown exponentially since 2001 [4] , including both premixed caffeinated alcoholic beverages and drinks mixed in bars or by oneself. While some caffeinated beer products were withdrawn from the market after protest from a coalition of US States' Attorney Generals, other premixed caffeinated alcoholic beverages remain commercially available and mixing the drinks oneself is common. Because caffeinated alcoholic beverages (CABs) are promoted as enhancing fun at parties or at bars [4] , mixing alcohol and energy drinks is likely to continue, even if the pre-mixed products are withdrawn. People who use energy drinks consume alcohol more frequently than people who do not use energy drinks [2, 5] ; a quarter of college students reported mixing alcohol and energy drinks in the past month [2] .
CABs may increase risk-taking behaviors. By offsetting the sedating effects of alcohol, CABs decrease feelings of intoxication [6, 7] , which may lead drinkers to believe that they are less impaired than they are, and thereby may induce more alcohol consumption. France and Denmark have banned the sale of energy drinks [4] and the governments of other countries (Canada and Sweden) have issued warnings about mixing energy drinks with alcohol. In 2009, the US FDA issued a statement expressing concerns about the lack of safety data on CABs (13 November 2009), because recent survey data [2] showed that CAB use correlated with risky behavior among college students. Students who consumed CABs, relative to those who consumed alcohol without caffeine, were more likely to: (1) be taken advantage of sexually; (2) take advantage of another sexually; (3) ride with an intoxicated driver; (4) be hurt or injured; and (5) require medical treatment [2] . Among lighter drinkers, those who consumed CABs were more likely to drive after drinking. Among patrons leaving a bar, those who had consumed CABs were three times more likely than those who drank non-caffeinated alcohol to leave the bar with a breath-alcohol content (BrAC) of Ն0.08 g% and four times as likely to intend to drive [8] .
The evidence is equivocal as to whether caffeine, when administered in a blinded experimental design, reduces alcohol-induced impairment. Some studies have found that caffeine acutely reverses alcohol-related performance impairment on tests of reaction time, divided attention and psychomotor speed, but not on error rates [9] [10] [11] [12] . Other studies did not find caffeine to reduce alcohol-induced impairment significantly in motor coordination and/or reaction time [6, [13] [14] [15] . It has been proposed that caffeine antagonizes alcohol's effects on response execution but not on inhibitory control [16] . The one study of caffeine-alcohol interaction effects on driving in a simulator found caffeine to partially counteract alcohol-induced impairment (0.085 g% BrAC) in brake latency, although performance remained more impaired in both alcohol conditions relative to placebo [17] .
The present study was designed to provide a controlled evaluation of the acute effects of caffeine on impairment after drinking to intoxication. Alcohol administration targeted BrAC of 0.12 g%, the level associated with hangover in most drinkers [18] (residual effects the next day are not reported here). Caffeine was added to alcoholic and non-alcoholic beer in the same proportion as in commercially available caffeinated beer and performance effects were evaluated using a driving simulator and a test of sustained attention/reaction time, both of which have been shown previously to be sensitive to acute alcohol effects [19] [20] [21] .
METHODS

Participants
Participants were volunteer university students and recent graduates from greater Boston, MA who were between 21 and 30 years of age and met the following criteria: (1) no drinking problems [score < 5 on the Short Michigan Alcohol Screening Test (SMAST)] [22] and no history of treatment or counseling for chronic alcohol problems; (2) Ն5 drinks on a single occasion (Ն4 if female) at least once in the 30 days prior to screening; (3) no health problems or current medication use contraindicated for alcohol; (4) no sleep disorders; (5) fluent English; (6) recently graduated from, or currently attending, an institution of higher learning; (7) not working night shifts at a job; (8) not a daily smoker; (9) not traveled across two or more time zones in the prior month; (10) negative pregnancy test and not nursing, if female; (11) Ն1 and Յ7 caffeinated beverages per day; and (12) Յ230 lb, to avoid caffeine and beverage loading. Females were not screened for menstrual cycle [23] [24] [25] . Regular tobacco users were excluded to avoid possible confounding due to nicotine withdrawal because, for safety reasons, participants were not allowed to leave the laboratory to smoke.
Participants were paid $150 upon completion of the study, or a pro-rated amount if their participation was terminated. The Institutional Review Boards at Boston Medical Center, Brown University, and the University of Michigan approved this study.
Study site
The study was conducted at the General Clinical Research Center (GCRC) at the Boston Medical Center campus.
Study design
We used a randomized between-groups 2 ¥ 2 factorial placebo-controlled design. One factor was alcohol versus placebo beverage; the other factor was caffeinated versus non-caffeinated beverage. Thus, participants received either: (1) caffeinated beer; (2) non-caffeinated beer; (3) caffeinated non-alcoholic beer; or (4) non-caffeinated non-alcoholic beer. This allowed investigation of main effects for caffeine and alcohol as well as interaction effects between the two substances. Acute effects were assessed on simulated driving and sustained attention/ reaction time following a 30-minute alcohol absorption period.
Recruitment and screening
Participants were recruited using newspaper advertisements and websites (i.e. FaceBook, Craig's List). Volunteers were screened by telephone and then onsite where they provided informed consent, were examined by a physician and given a study orientation. After the orientation, participants practiced on the driving simulator and the sustained attention/reaction time test to eliminate learning effects.
Pre-session requirements and session procedures
To reduce potential confounding by sleep deprivation and sleep schedule irregularity, participants were instructed to maintain an 8-hour time in bed schedule for the 3 nights prior to the experimental session, confirmed by daily sleep/wake diary and call-in to a time-stamped answering machine. They were prohibited from napping 24 hours prior to beverage administration; required to pass a pregnancy test (females) and a breath alcohol test; and were required to abstain from alcohol, medications not already approved by the study physician, sleep aids and recreational drugs for 24 hours and caffeine for 8 hours, prior to their experimental session.
A week after screening, participants returned for the experimental session at 4:00 p.m. in groups of up to five. Car keys were collected if participants drove to the site to prevent drunken driving if a participant dropped out of the study during or after alcoholic beverage administration. Following a standardized dinner, participants were screened for breath alcohol and pregnancy (if female). Participants who were compliant with the pre-laboratory regimen and who were not pregnant were randomized to experimental condition. Beverage administration followed the procedures below. Thirty minutes following beverage administration, participants performed the driving simulator and the sustained attention/reaction time test, received snacks, and prepared for bed.
Beverage administration procedures
The beverage administration procedures followed the guidelines for balanced placebo studies [26] and the [27] . To maintain double-blinding, the research staff who prepared beverages and conducted breath tests were different from those who collected all other measures.
Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation
Alcoholic beverage administration targeted 0.12 g% BrAC, adjusting for sex (1.068 g/kg body weight for men and 0.915 g/kg for women), as per Friel [28] . If participants randomized to alcohol did not reach 0.12 g% BrAC after receiving the prescribed amount of beverage, the ratio of obtained versus target BrAC was used to determine the additional amount of beer to be administered. To maintain blinding, the same number of placebo participants was given a matching extra dose. Hurricane High Gravity™ (8.1%) beer (Anheuser Busch, St Louis, MO, USA) and Clausthaler™ nonalcoholic beer (<0.01%) (Radeberger Gruppe KG, Frankfurt am Main, Germany) were the beverages. High alcohol-content beer reduces the volume required to attain the targeted dose. Beer controlled with nonalcoholic beer is an effective beverage combination for the balanced placebo design [29] . Participants who received alcoholic beer received a mean of 44 oz of beverage (37 if female), the equivalent of 6.2 12-oz. (4.8% alc. by vol.) cans. Although beer is absorbed more slowly than spirits it was chosen for ecological validity, as most young adults consume beer.
To caffeinate the alcoholic and placebo beverages, 117 mg of tasteless, anhydrous caffeine powder in solution was added to each 12-oz unit via a pre-packaged syringe, prepared by a compounding pharmacy (Pawtuxet Valley Prescription & Surgical Center, Inc., Coventry, RI, USA). This dose approximates the caffeine content found in a commercially available caffeinated beer (Moonshot ® ) that contains 4.8% alcohol by volume and 69 ml of caffeine in each 12-oz bottle. On average, participants who received caffeine received 383 mg of caffeine (338 if female). Our weight exclusion ensured that no participant received more than 650 mg of caffeine.
Beverage administration began at 7:30 p.m., 3 hours after participants completed their meals, and continued until approximately 8:30 p.m. Participants were told that there was a 25% chance of being assigned to one of the four experimental conditions and that they should not sniff or taste each other's drinks, nor discuss which beverage they believed they had received. As a manipulation check, a blinded staff member was present throughout beverage administration to monitor and record participants' consumption. Participants were breath-tested, using Intoximeters' AlcoSensor-4 (Intoximeters, Inc., St Louis, MO, USA): after they consumed half their prescribed dose; when they consumed their full prescribed dose; after re-dosing (if participants were not at 0.12 g% BrAC after finishing their prescribed dose); and every 15 minutes thereafter, until a final breath test was taken. Participants had an 8-hour (11:00 p.m.-7:00 a.m.) sleep opportunity, during which they were monitored for safety by an emergency medical technician (EMT) on staff to the study.
Measures
Individual difference measures
Participant demographics were recorded at enrollment. Average daily volume (ADV) of alcohol intake was calculated to establish recent drinking practices using a twoitem alcohol use questionnaire: (1) 'Considering all your drinking times in the past 30 days, about how often did you have any beer, wine or liquor?', Likert-rated from 1 'once a day' to 7 'did not drink' with each point anchored; and (2) 'In the past 30 days, on a typical day that you drank, about how much did you have to drink in one day?', rated from 1 to 8, with choices of '1 to 7 drinks' and '8 or more drinks'. (One drink was defined as 12 oz of beer or wine cooler, 4 oz of wine or 1 oz of liquor.) ADV is the product of the two.
Simulated driving task
The 30-minute driving task, sensitive to sleepiness and alcohol [21, 30, 31] , was run on a computer with 
Sustained attention/reaction time
This critical component of safe driving was measured using the Psychomotor Vigilance Task (PVT; Ambulatory Monitoring, Inc, Ardsley, New York, USA). The PVT is a hand-held 10-minute visually sustained attention test shown to be sensitive to alcohol effects [19, 20] . Participants pressed a button as quickly as possible in response to numbers scrolling on the LCD screen, with a random 2-10-second inter-stimulus interval. Response time was counted in milliseconds by a solid-state storage unit for downloading to a computer. The primary outcome variable was median reaction time [32] .
Self-reported estimate of blood alcohol concentration (BAC)
To determine whether the coadministration of alcohol and caffeine affects perceptions of intoxication, relative to alcohol alone, participants estimated their blood alcohol level following beverage administration and absorption period on a scale from 0 to 0.15 g% using a questionnaire we developed for previous studies, the Self Estimate of Blood Alcohol Concentration (SEBAC).
Data analysis approach
All measures were examined for normality and outliers. Speed and lane variability were log-transformed to correct for non-normality in the data. Outliers were recoded following recommendations by Tabachnick & Fidell [33] . Analysis of variance (2 ¥ 2) investigated the main effects of alcohol and caffeine and their interaction on the speed and lane variables of the simulated driving task and on median PVT reaction time. Effect sizes are reported in terms of Cohen's f [34] ), where f < 0.25 is small, between 0.25 and 0.39 is medium, and 0.40 and above is large. A negative binomial regression model for count data, with a log offset to account for minor variations in length of simulator run time, was used to analyze crashes on the driving simulator.
With a targeted sample of 133 participants available for analysis, our study had 80% power of detecting the anticipated medium-sized main effect of acute alcohol or caffeine on simulated driving performance.
RESULTS
Participant enrollment and characteristics
Two hundred and twenty-four volunteers were screened by telephone, of whom 49 (21.8%) did not meet inclusion criteria and another 21 (9.4%) were eligible but subsequently declined participation. Of 154 who signed consent, 12 (7.8%) did not present for the experimental sessions and 13 were excluded because of an error in caffeine administration. Of the 129 participants who completed the study, eight were eliminated from the analysis of the driving simulator data because of technical problems with the simulator and two were excluded because they had difficulty operating the PVT. Thus, 121 participants were available for the analysis of simulated driving performance and 127 participants were available for PVT analysis.
Fifty-three per cent of participants were male; 75% were white; 10% were Hispanic; 83% were students and 17% were recent graduates. Participants' mean age was 22.9 [standard deviation (SD) = 2.23; range 21-30 years]; ADV was 1.60 (SD = 1.03; range 0.10-4.74 drinks); mean days buzzed in last 30 days was 7.2 (SD = 5.04; range 1.5-25.8 days). Mean peak BrAC for participants receiving alcohol was 0.12 g% (SD = 0.012); range 0.08-0.16 g%). There were no significant differences across the four experimental groups on these variables.
Dependent measures of objective effects
Speed deviation
The effect of alcohol was borderline significant, F(1,117) = 2.78, P = 0.10, with a small effect size f = 0.15 (see Table 1 for means). Mean speed deviation was 3.8 (SD = 7.8) mph after alcohol compared to 1.6 (SD = 5.1) mph after non-alcoholic beer. No significant effect of caffeine (F(1,117) = 0.01, effect size f = 0.01) and no significant interaction (F(1,117) = 1.58, effect size f = 0.11) was found.
Speed variability
The effect of alcohol was significant, F(1,117) = 11.92, P < 0.001, with a medium effect size f = 0.32 (see Table 1 for means). Speed variability was 10.8 (SD = 7.9) mph after alcohol compared to 6.7 (SD = 3.3) mph after non-alcoholic beer. No significant effect of caffeine (F(1,117) = 0.22, effect size f = 0.04) and no significant interaction (F = 0.15, effect size f = 0.03) were found.
Lane position deviation
The effect of alcohol was not significant, F(1,117) = 0.48, with a very small effect size f = 0.06 (see Table 1 for means). No significant effect of caffeine (F(1,117) = 0.13, effect size f = 0.03) and no significant interaction (F(1,117) = 0.20, effect size f = 0.04) were found.
Lane position variability
The effect of alcohol was significant, F(1,117) = 22.09, P < 0.001, with a large effect size f = 0.43 (see Table 1 for means). Mean standard deviation for lane deviation was 1.43 (SD = 0.55) feet after alcohol compared to 1.09 (SD = 0.41) feet after non-alcoholic beer. The effect of caffeine was borderline significant (F(1,117) = 2.89, P = 0.09, with a small effect size f = 0.14). Mean standard deviation for lane deviation was 1.21 (SD = 0.54) feet after caffeine compared to 1.31 (SD = 0.50) feet after non-caffeinated beverage. No significant interaction (F(1,117) = 2.44, effect size f = 0.13) was found.
Crashes
No significant interaction [c 2 ( df = 1) = 2.34] was found [see Table 1 
Sustained attention/reaction time
The effect of alcohol was significant, F(1,123) = 52.30, P < 0.001, with a large effect size f = 0.64 (see Table 1 for Table 1 Acute effects of alcohol and caffeine beverage manipulations on speed (mph) and lane (feet) deviation means and average standard deviations (SD) and on attention/reaction time (milliseconds).
Alcoholic beer
Non-alcoholic beer 
Self-reported estimate of BAC
There was no difference in the estimate of BrAC between participants who received caffeinated beer (0.11 Ϯ 0.02 g%) and non-caffeinated beer (0.10 Ϯ 0.02 g%) BrAC.
DISCUSSION
Our findings indicate that under acute intoxication caffeine, in the amounts found typically in CABs, does not reduce alcohol-related impairment in simulated driving or sustained attention/reaction time. Alcohol intoxication resulted in more variability in speed and lateral movements and increased crashes. However, there appears to be little or no protective benefit from the addition of caffeine to alcohol with respect to the safe execution of activities that require sustained attention with rapid accurate decisions. These findings do not appear to result from insufficient statistical power, as the interactions effect sizes were all very small and not of a meaningful size. These findings are consistent with those of Liguori & Robinson [17] , who did not find large effects of caffeinated versus non-caffeinated alcohol on braking latency in a driving simulator or on choice reaction time. Other investigators, however, found that CABs decreased self-perceived intoxication [6, 7] . We did not find differences in self-estimated BrAC among those who received alcohol with and without caffeine, suggesting that people can evaluate their level of intoxication accurately following consumption of these beverages.
These findings are important within the context of the current interest in the safety of CABs by the US FDA and regulatory agencies in other countries. Despite marketing claims, and consistent with a number of other studies reviewed above, adding caffeine to alcohol has no beneficial effects on performance relevant to safety at these intoxicating doses. Given that expecting beneficial effects from caffeine worsens performance after alcohol, when people are told that they have caffeine added to alcohol [35] [36] [37] , harmful effects may occur in the natural environment where the beverages are consumed, with the expectation that caffeine will offset alcohol's impairing effects.
The results of this study suggest that public education, via media and warning labels, should be considered regarding the safety of CABs and that regulators should scrutinize energy drinks and CAB advertising activities as they relate to promoting safety-related expectancies.
The limitations of this study included a restricted age range, using only one dose of alcohol and of caffeine, and not assessing decision to drive. Results may be different at lower alcohol, or higher caffeine, levels. Further research should examine whether, relative to non-caffeinated alcoholic beverages, CABs increase urge to drink more and affect risk-taking decision making.
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